SS Lynch, CM Cheng - Annals of Pharmacotherapy, 2007 - Harvey Whitney Books Low vision and blindness, respectively, affect an estimated 2.4 million Amer- icans and 937 000 of
those over the age of 40 years. It is expected that 5.5 mil- lion Americans will be affected by
these conditions by the year 2020. ... Cited by 49 - Related articles - BL Direct - All 4 versions
DT Azar - Transactions of the American Ophthalmological Society, 2006 - pubmedcentral.nih.gov Immunohistochemistry demonstrated the presence of antiangiogenic factors (PEDF, angiostatin, restin,
and endostatin) and proangiogenic molecules (VEGF, bFGF, MMP-2, and MT1-MMP) in the cornea after
wounding. Proangiogenic MMPs were ... Cited by 33 - Related articles - All 4 versions
TY Wong, G Liew, P Mitchell - The Lancet, 2007 - Elsevier Whilst these new treatments are appropriately seen as important breakthroughs in AMD management, the
long-term systemic safety of intravitreal anti-VEGF drugs remains unclear. Several concerns have not
yet been addressed. First, although ... Cited by 23 - Related articles - All 11 versions
- ►sgmjournals.org W James - Journal of General Virology, 2007 - Soc General Microbiol Aptamers are artificial nucleic acid ligands that can be generated in vitro against a wide range of
molecules, including the gene products of viruses. Aptamers are isolated from complex libraries of
synthetic nucleic acids by an ... Cited by 17 - Related articles - BL Direct - All 8 versions
- ►prsjournal.com MM Brown, GC Brown, H Brown - Current Opinion in Ophthalmology, 2007 - journals.lww.com Purpose of review The aim of this article is to review the patient value conferred by interventions
for neovascular macular degeneration. Recent findings Value-based medicine is the practice of
medicine based upon the patient ... Cited by 9 - Related articles - BL Direct - All 4 versions
- ►augenaerzte-baden-baden.de [PDF] AJ Augustin, I Offermann - Expert Opin. Emerging Drugs, 2006 - informahealthcare.com Age-related macular degeneration (AMD) is a leading cause of blindness that until recently had no
recognised drug treatment. In wet AMD, choroidal neovascularisation (CNV) causes a profound loss of
central vision. CNV is a complex ... Cited by 8 - Related articles - All 7 versions
- ►prsjournal.com AJ Augustin, I Offermann - Drugs &# 38; Aging, 2007 - ingentaconnect.com Choroidal neovascularisation (CNV) often leads to severe vision loss and is Abstract becoming
increasingly prevalent as the aging population grows. Age-related macular degeneration (AMD) is the
most common cause of CNV, but CNV ... Cited by 7 - Related articles - BL Direct - All 8 versions
- ►prsjournal.com C Incorvaia, C Campa, F Parmeggiani, M Menzione, S … - Retina, 2008 - journals.lww.com Purpose: To evaluate the 12-month visual outcome of photodynamic therapy with verteporfin (PDT-V)
for patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular
degeneration and to verify the ... Cited by 4 - Related articles - BL Direct - All 3 versions
- ►duanessolution.com F Parmeggiani, C Costagliola, D Gemmati, S … - Pharmacogenetics …, 2007 - journals.lww.com Page 1. Original article 1039 Predictive role of coagulation-balance gene polymorphisms in the efficacy
of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related
macular degeneration Francesco Parmeggiani a , Ciro Costagliola c , Donato Gemmati b , ... Cited by 3 - Related articles - BL Direct - All 8 versions
